Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma. [electronic resource]
Producer: 20100122Description: 36-41 p. digitalISSN:- 1198-0052
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.